Viewing StudyNCT00002208



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002208
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Multicenter Open-Label Randomized 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate 800 Mg q 8 h Versus 1200 Mg q 12 h in Combination With Zidovudine and 3TC
Sponsor: Merck Sharp Dohme LLC
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Reverse Transcriptase Inhibitors View
HIV-1 View
Drug Therapy Combination View
Zidovudine View
HIV Protease Inhibitors View
Lamivudine View
Indinavir View